Latest Biotechnology, Pharmaceutical and Healthcare News from Drug Discovery Today

18:11 EDT 21st March 2018 | BioPortfolio

Here are the most relevant search results for "Drug Discovery Today" found in our extensive news archives from over 250 global news sources.

More Information about Drug Discovery Today on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Drug Discovery Today for you to read. Along with our medical data and news we also list Drug Discovery Today Clinical Trials, which are updated daily. BioPortfolio also has a large database of Drug Discovery Today Companies for you to search.

Showing News Articles 1–25 of 144 from Drug Discovery Today

Tuesday 20th March 2018

The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the ‘Lab of the Future’

EU conference and two-day ‘hack the lab’ hackathon discusses how artificial intelligence (AI) and the Internet of Things (IoT) will impact life sciences

Wednesday 14th March 2018

The Current issue of “The view from here” is concerned with Peptides.

The topic of this month’s newsletter from Drug Discovery Today is “Peptides”

Tuesday 13th March 2018

Steering Group calls for action in fighting influenza

EU Manifesto on Influenza Vaccination launched detailing key strategies to improve influenza vaccination coverage rates in Europe

Monday 12th March 2018

New Research Uncovers How Cancer Stem Cells Drive Triple-Negative Breast Cancer

Findings published in Nature Communications identify stem cell survival pathway, which may serve as a potential target for new breast cancer therapies

Thursday 8th March 2018

Phenomics Discovery Initiative expands portfolio to new disease areas, translating the best biology into novel therapeutics

The Phenomics Discovery Initiative (PDi) has expanded its assay portfolio to a total of 11 complex phenotypic assays that are relevant to human pathophysiology in areas of unmet clinical need including neuropsychiatric illnesses, dementia, cancer and respiratory infections.

First patient treated in Follicum’s Phase IIa study of FOL-005 for stimulation of hair growth

Follicum AB have announced that the firstpatient has been treated in the Phase IIa clinical trial in Germany with its lead candidate FOL-005 on 60 patients with hair loss. The study is conducted at Clinical Research Center for Hair and Skin Science (“CRC”) in Berlin and bioskin, Hamburg, Germany. The global market for pharmaceutical hair lossproducts for both men and women is estimated to be ...

Wednesday 7th March 2018

Gene By Gene Selects BC Platforms to enhance its world leading Genomic data processing services.

BC Platforms, a world leader in genomic data management and analytics, announces that it has been selected by Gene By Gene, the industry leader in offering integrated multi-disciplinary genetic testing services, to scale up its genomic data processing and storage capabilities.

Enhancement of neurotrophic factor signalling may improve memory functions

Treatments targeted to enhance brain neurotrophic factor signalling could improve memory functions in Alzheimer’s disease even though they don’t alter brain amyloid burden, according to recent research from the University of Eastern Finland. The enhancement of brain derived neurotrophic factor (BDNF) signalling alleviated memory impairment in Alzheimer’s mouse models. In addition, the admini...

Tuesday 6th March 2018

BC Platforms Launches an End-to-End Solution for Precision Medicine powered by the Microsoft Genomics Service

BC Platforms, a pioneer in genomic data management and analytics, today announces it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses the Microsoft Genomics service which runs on Microsoft Azure. GeneVision provides end-to-end Software-as-a-Service solution from raw genome data to patient reports, implemented using Azure services. GeneVision utilizes several o...

How a Yeast Cell Helps Crack Open the “Black Box” Behind Artificial Intelligence

“It seems like every time you turn around, someone is talking about the importance of artificial intelligence and machine learning,” said Trey Ideker, PhD, University of California San Diego School of Medicine and Moores Cancer Center professor. “But all of these systems are so-called ‘black boxes.’ They can be very predictive, but we don’t actually know all that much about how they wo...

Thursday 1st March 2018

Cell and Gene Therapy Catapult enters into partnership with the Japanese Society for Regenerative Medicine

Memorandum of Understanding between CGT Catapult and JSRM further enhances the UK’s relationship with regenerative medicine centres in Japan and contributes to the advancement of cell and gene therapies worldwide

Wednesday 28th February 2018

The Current issue of “The view from here” is concerned with Regulatory aspects of Drug Discovery.

The topic of this month’s newsletter from Drug Discovery Today is “Regulatory aspects of Drug Discovery”.

Thursday 8th February 2018

TC Biopharm and the NIPRO Corporation Announce Strategic Programme Co-Developing a Novel Gamma-Delta Car-T Product to Treat Cancer

Scottish Enterprise will contribute £2.7m via a ‘seek and solve’ grant to fund pre-clinical activities

Wednesday 7th February 2018

Musical molecules and the battle for biological supremacy

The battle for supremacy between bacteria and antibiotics normally goes unseen, either behind closed doors in the laboratory or concealed deep within the human body. But now that complex contest is being translated into music thanks to a performance in which the worlds of art and science will combine to striking effect.

Friday 2nd February 2018

Elsevier Welcomes Six Biotech and Pharma Start-ups to The Hive, Supporting the Most Cutting-edge Research in Industry

Start-ups working on a range of technologies and discoveries - from AI to immunotherapy - receive complimentary access to Elsevier's information solutions to accelerate innovation

Thursday 1st February 2018

New project to transform biologics manufacture

The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, today announced that it is in the final stages of a BBSRC-funded collaboration project with the University of Edinburgh’s Roslin Institute, to transform the way in which valuable proteins are manufactured for research, veterinary and human health. The project, hosted at CPI’s state-of-...

Friday 26th January 2018

The Current issue of “The view from here” is concerned with Medicinal Chemistry

The topic of this month’s newsletter from Drug Discovery Today is “Medicinal Chemistry””.

Thursday 25th January 2018

Drug trial protocol redactions by industry sponsors exposed

Trial protocols are needed for a proper assessment of the veracity of drug trial reports. The researchers, from the Nordic Cochrane Centre in Copenhagen, found widespread redactions in the protocols for commercially sponsored trials they received from research ethics committees in Denmark. The study is believed to be the first systematic assessment of which information in trial protocols pharmaceu...

Wednesday 24th January 2018

New report reveals UK has the strongest R&D pipeline in Europe and the UK sector is maturing

‘Pipeline Progressing: the UK’s global bioscience cluster in 2017’ launched by the BioIndustry Association and Informa Pharma Intelligence

Wednesday 10th January 2018

ZINPLAVA®? (bezlotoxumab) - a new therapy for the prevention of recurrence of Clostridium difficile infection - launched in the UK

Bezlotoxumab is the first EC licensed non-antibiotic option indicated to prevent Clostridium difficile infection (CDI) recurrence in high-risk adults

Tuesday 9th January 2018

44% of Life Science Professionals Already Using or Experimenting with AI and Deep Learning, Finds Survey from The Pistoia Alliance

94% expect an increase in use of Machine Learning within two years, but access to quality data and technical expertise is a barrier to adoption

Thursday 4th January 2018

Nintedanib awarded Promising Innovative Medicine designation for malignant pleural mesothelioma with phase II trial showing progression-free survival benefit when added to first-line chemotherapy

Nintedanib has been designated a Promising Innovative Medicine for the treatment of malignant pleural mesothelioma (MPM) by the UK Medicine and Healthcare Products Regulatory Agency (MHRA). This is an early indication that the MHRA considers nintedanib a promising candidate for the Early Access to Medicines Scheme, which aims to give patients with life threatening or seriously debilitating conditi...

Tuesday 2nd January 2018

AstraZeneca and Imperial College London Establish Research Collaboration to Investigate Biological Drivers of Respiratory Disease

AstraZeneca and Imperial College London have announced a new research collaboration in respiratory disease which will see their scientists working side-by-side to investigate basic scientific mechanisms and underlying drivers of conditions such as asthma and chronic obstructive pulmonary disease (COPD).

Thursday 21st December 2017

The Current issue of “The view from here” is concerned with the best of 2017

The topic of this month’s newsletter from Drug Discovery Today is “the best of 2017””.

Wednesday 13th December 2017

UK and Russian researchers join forces against AMR

Two of the key organisations in the UK and Russia leading efforts to combat the global problem of antimicrobial resistance (AMR) have today announced a formal agreement to work together.

Quick Search


News Quicklinks